+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioengineered Protein Drugs - Market Analysis, Trends, and Forecasts

  • ID: 1382359
  • Report
  • 250 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott India
  • Bayer Ag
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Novartis International Ag
  • MORE
The Bioengineered Protein Drugs market worldwide is projected to grow by US$122 Billion, driven by a compounded growth of 7.1%. Monoclonal Antibodies, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$134.1 Billion by the year 2025, Monoclonal Antibodies will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$4.3 Billion to the region's size and clout in the next 5 to 6 years. Over US$3.7 Billion worth of projected demand in the region will come from the rest of the European markets. In Japan, Monoclonal Antibodies will reach a market size of US$6.8 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$33.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott India Ltd.
  • Amgen, Inc.
  • Bayer AG
  • Biocon Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Panacea Biotec Ltd.
  • ProBioGen AG
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott India
  • Bayer Ag
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Novartis International Ag
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Bioengineered Protein Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Bioengineered Protein Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Bioengineered Protein Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Bioengineered Protein Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Monoclonal Antibodies (Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Monoclonal Antibodies (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Monoclonal Antibodies (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Therapeutic Proteins (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Therapeutic Proteins (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Therapeutic Proteins (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Vaccines (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Vaccines (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Vaccines (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Pharma & Biotech Companies (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025

TABLE 14: Pharma & Biotech Companies (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017

TABLE 15: Pharma & Biotech Companies (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: CROs (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 17: CROs (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017

TABLE 18: CROs (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Academics (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025

TABLE 20: Academics (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017

TABLE 21: Academics (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Bioengineered Protein Drugs Market Share (in %) by Company: 2019 & 2025

TABLE 22: United States Bioengineered Protein Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 23: Bioengineered Protein Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017

TABLE 24: United States Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 25: United States Bioengineered Protein Drugs Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025

TABLE 26: Bioengineered Protein Drugs Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017

TABLE 27: Bioengineered Protein Drugs Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025

CANADA

TABLE 28: Canadian Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 29: Canadian Bioengineered Protein Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 30: Bioengineered Protein Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 31: Canadian Bioengineered Protein Drugs Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 32: Bioengineered Protein Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 33: Canadian Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

JAPAN

TABLE 34: Japanese Market for Bioengineered Protein Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 35: Bioengineered Protein Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 36: Japanese Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 37: Japanese Demand Estimates and Forecasts for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 38: Japanese Bioengineered Protein Drugs Market in US$ Million by End-Use: 2009-2017

TABLE 39: Bioengineered Protein Drugs Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025

CHINA

TABLE 40: Chinese Bioengineered Protein Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 41: Bioengineered Protein Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017

TABLE 42: Chinese Bioengineered Protein Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 43: Chinese Demand for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 44: Bioengineered Protein Drugs Market Review in China in US$ Million by End-Use: 2009-2017

TABLE 45: Chinese Bioengineered Protein Drugs Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

EUROPE

Market Facts & Figures

European Bioengineered Protein Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 46: European Bioengineered Protein Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 47: Bioengineered Protein Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 48: European Bioengineered Protein Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 49: European Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 50: Bioengineered Protein Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 51: European Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 52: European Bioengineered Protein Drugs Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 53: Bioengineered Protein Drugs Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 54: European Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

FRANCE

TABLE 55: Bioengineered Protein Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 56: French Bioengineered Protein Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 57: French Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 58: Bioengineered Protein Drugs Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025

TABLE 59: French Bioengineered Protein Drugs Historic Market Review in US$ Million by End-Use: 2009-2017

TABLE 60: French Bioengineered Protein Drugs Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

GERMANY

TABLE 61: Bioengineered Protein Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 62: German Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 63: German Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 64: Bioengineered Protein Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025

TABLE 65: German Bioengineered Protein Drugs Market in Retrospect in US$ Million by End-Use: 2009-2017

TABLE 66: Bioengineered Protein Drugs Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025

ITALY

TABLE 67: Italian Bioengineered Protein Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 68: Bioengineered Protein Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017

TABLE 69: Italian Bioengineered Protein Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 70: Italian Demand for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 71: Bioengineered Protein Drugs Market Review in Italy in US$ Million by End-Use: 2009-2017

TABLE 72: Italian Bioengineered Protein Drugs Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

UNITED KINGDOM

TABLE 73: United Kingdom Market for Bioengineered Protein Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 74: Bioengineered Protein Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 75: United Kingdom Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 76: United Kingdom Demand Estimates and Forecasts for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 77: United Kingdom Bioengineered Protein Drugs Market in US$ Million by End-Use: 2009-2017

TABLE 78: Bioengineered Protein Drugs Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025

SPAIN

TABLE 79: Spanish Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 80: Spanish Bioengineered Protein Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 81: Bioengineered Protein Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 82: Spanish Bioengineered Protein Drugs Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 83: Bioengineered Protein Drugs Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 84: Spanish Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

RUSSIA

TABLE 85: Russian Bioengineered Protein Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 86: Bioengineered Protein Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017

TABLE 87: Russian Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 88: Russian Bioengineered Protein Drugs Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025

TABLE 89: Bioengineered Protein Drugs Historic Demand Patterns in Russia by End-Use in US$ Million for 2009-2017

TABLE 90: Bioengineered Protein Drugs Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 91: Rest of Europe Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 92: Bioengineered Protein Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 93: Rest of Europe Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 94: Rest of Europe Bioengineered Protein Drugs Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 95: Bioengineered Protein Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 96: Rest of Europe Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 97: Asia-Pacific Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 98: Bioengineered Protein Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 99: Asia-Pacific Bioengineered Protein Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 100: Bioengineered Protein Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 101: Asia-Pacific Bioengineered Protein Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 102: Asia-Pacific Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 103: Bioengineered Protein Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025

TABLE 104: Asia-Pacific Bioengineered Protein Drugs Historic Market Review in US$ Million by End-Use: 2009-2017

TABLE 105: Asia-Pacific Bioengineered Protein Drugs Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

AUSTRALIA

TABLE 106: Bioengineered Protein Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 107: Australian Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 108: Australian Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 109: Bioengineered Protein Drugs Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025

TABLE 110: Australian Bioengineered Protein Drugs Market in Retrospect in US$ Million by End-Use: 2009-2017

TABLE 111: Bioengineered Protein Drugs Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025

INDIA

TABLE 112: Indian Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 113: Indian Bioengineered Protein Drugs Historic Market Review by Type in US$ Million: 2009-2017

TABLE 114: Bioengineered Protein Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 115: Indian Bioengineered Protein Drugs Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 116: Bioengineered Protein Drugs Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 117: Indian Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

SOUTH KOREA

TABLE 118: Bioengineered Protein Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 119: South Korean Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 120: Bioengineered Protein Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025

TABLE 121: Bioengineered Protein Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025

TABLE 122: South Korean Bioengineered Protein Drugs Historic Market Analysis in US$ Million by End-Use: 2009-2017

TABLE 123: Bioengineered Protein Drugs Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 124: Rest of Asia-Pacific Market for Bioengineered Protein Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 125: Bioengineered Protein Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 126: Rest of Asia-Pacific Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 127: Rest of Asia-Pacific Demand Estimates and Forecasts for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 128: Rest of Asia-Pacific Bioengineered Protein Drugs Market in US$ Million by End-Use: 2009-2017

TABLE 129: Bioengineered Protein Drugs Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 130: Latin American Bioengineered Protein Drugs Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 131: Bioengineered Protein Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 132: Latin American Bioengineered Protein Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 133: Latin American Bioengineered Protein Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 134: Bioengineered Protein Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017

TABLE 135: Latin American Bioengineered Protein Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 136: Latin American Demand for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 137: Bioengineered Protein Drugs Market Review in Latin America in US$ Million by End-Use: 2009-2017

TABLE 138: Latin American Bioengineered Protein Drugs Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

ARGENTINA

TABLE 139: Argentinean Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 140: Bioengineered Protein Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 141: Argentinean Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 142: Argentinean Bioengineered Protein Drugs Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 143: Bioengineered Protein Drugs Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 144: Argentinean Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

BRAZIL

TABLE 145: Bioengineered Protein Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 146: Brazilian Bioengineered Protein Drugs Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 147: Brazilian Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 148: Bioengineered Protein Drugs Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2018-2025

TABLE 149: Brazilian Bioengineered Protein Drugs Historic Market Review in US$ Million by End-Use: 2009-2017

TABLE 150: Brazilian Bioengineered Protein Drugs Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025

MEXICO

TABLE 151: Bioengineered Protein Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 152: Mexican Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 153: Mexican Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 154: Bioengineered Protein Drugs Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025

TABLE 155: Mexican Bioengineered Protein Drugs Market in Retrospect in US$ Million by End-Use: 2009-2017

TABLE 156: Bioengineered Protein Drugs Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 157: Rest of Latin America Bioengineered Protein Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 158: Bioengineered Protein Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017

TABLE 159: Rest of Latin America Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 160: Rest of Latin America Bioengineered Protein Drugs Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025

TABLE 161: Bioengineered Protein Drugs Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2009-2017

TABLE 162: Bioengineered Protein Drugs Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 163: The Middle East Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 164: Bioengineered Protein Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 165: The Middle East Bioengineered Protein Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 166: The Middle East Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 167: The Middle East Bioengineered Protein Drugs Historic Market by Type in US$ Million: 2009-2017

TABLE 168: Bioengineered Protein Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 169: The Middle East Bioengineered Protein Drugs Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025

TABLE 170: Bioengineered Protein Drugs Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017

TABLE 171: The Middle East Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

IRAN

TABLE 172: Iranian Market for Bioengineered Protein Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 173: Bioengineered Protein Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 174: Iranian Bioengineered Protein Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 175: Iranian Demand Estimates and Forecasts for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 176: Iranian Bioengineered Protein Drugs Market in US$ Million by End-Use: 2009-2017

TABLE 177: Bioengineered Protein Drugs Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025

ISRAEL

TABLE 178: Israeli Bioengineered Protein Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 179: Bioengineered Protein Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 180: Israeli Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 181: Israeli Bioengineered Protein Drugs Addressable Market Opportunity in US$ Million by End-Use: 2018-2025

TABLE 182: Bioengineered Protein Drugs Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017

TABLE 183: Israeli Bioengineered Protein Drugs Market Share Analysis by End-Use: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 184: Saudi Arabian Bioengineered Protein Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 185: Bioengineered Protein Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017

TABLE 186: Saudi Arabian Bioengineered Protein Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 187: Saudi Arabian Demand for Bioengineered Protein Drugs in US$ Million by End-Use: 2018 to 2025

TABLE 188: Bioengineered Protein Drugs Market Review in Saudi Arabia in US$ Million by End-Use: 2009-2017

TABLE 189: Saudi Arabian Bioengineered Protein Drugs Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025

UNITED ARAB EMIRATES

TABLE 190: Bioengineered Protein Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 191: United Arab Emirates Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 192: Bioengineered Protein Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025

TABLE 193: Bioengineered Protein Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025

TABLE 194: United Arab Emirates Bioengineered Protein Drugs Historic Market Analysis in US$ Million by End-Use: 2009-2017

TABLE 195: Bioengineered Protein Drugs Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 196: Bioengineered Protein Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 197: Rest of Middle East Bioengineered Protein Drugs Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 198: Rest of Middle East Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 199: Bioengineered Protein Drugs Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025

TABLE 200: Rest of Middle East Bioengineered Protein Drugs Market in Retrospect in US$ Million by End-Use: 2009-2017

TABLE 201: Bioengineered Protein Drugs Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025

AFRICA

TABLE 202: African Bioengineered Protein Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 203: Bioengineered Protein Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017

TABLE 204: African Bioengineered Protein Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 205: African Bioengineered Protein Drugs Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025

TABLE 206: Bioengineered Protein Drugs Historic Demand Patterns in Africa by End-Use in US$ Million for 2009-2017

TABLE 207: Bioengineered Protein Drugs Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

ABBOTT INDIA

AMGEN

BAYER AG

BIOCON

DR. REDDY'S LABORATORIES

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

JOHNSON & JOHNSON

MERCK & CO., INC.

NOVARTIS INTERNATIONAL AG

PANACEA BIOTEC

PROBIOGEN AG

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott India
  • Amgen
  • Bayer Ag
  • Biocon
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International Ag
  • Panacea Biotec
  • Probiogen Ag
Note: Product cover images may vary from those shown
Adroll
adroll